Paraspinal Myositis in Patients with COVID-19 Infection

References

1. 1.↵
   1. Zeng Z,
   2. Xu L,
   3. Xie XY, et al

   . Pulmonary pathology of early phase COVID-19 pneumonia in a patient with a benign lung lesion. Histopathology 2020 May 6. [Epub ahead of print] doi:10.1111/his.14138 pmid:32374419

   CrossRefPubMed
2. 2.↵
   1. Jafari R,
   2. Cegolon L,
   3. Jafari A, et al

   . Large saddle pulmonary embolism in a woman infected by COVID-19 pneumonia. Eur Heart J 2020;41:2133 doi:10.1093/eurheartj/ehaa402 pmid:32374381

   CrossRefPubMed
3. 3.↵
   1. Ji M,
   2. Yuan L,
   3. Shen W, et al

   . Characteristics of disease progress in patients with coronavirus disease 2019 in Wuhan, China. Epidemiol Infect 2020;148:e94 doi:10.1017/S0950268820000977 pmid:32374248

   CrossRefPubMed
4. 4.↵
   1. Yu Q,
   2. Wang Y,
   3. Huang S, et al

   . Multicenter cohort study demonstrates more consolidation in upper lungs on initial CT increases the risk of adverse clinical outcome in COVID-19 patients. Theranostics 2020;10:5641–48 doi:10.7150/thno.46465

   CrossRef
5. 5.↵
   1. Wu J,
   2. Pan J,
   3. Teng D, et al

   . Interpretation of CT signs of 2019 novel coronavirus (COVID-19) pneumonia. Eur Radiology 2020 May 4. [Epub ahead of print] doi:10.1007/s00330-020-06915-5 pmid:32367422

   CrossRefPubMed
6. 6.↵
   1. Pozzessere C,
   2. Rotzinger DC,
   3. Ghaye B, et al

   . Incidentally discovered COVID-19 pneumonia: the role of diagnostic imaging. Eur Radiology 2020 May 4. [Epub ahead of print] doi:10.1007/s00330-020-06914-6 pmid:32367421

   CrossRefPubMed
7. 7.↵
   1. Liya G,
   2. Yuguang W,
   3. Jian L, et al

   . Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review. APMIS 2020 May 4. [Epub ahead of print] doi:10.1111/apm.13047 pmid:32363707

   CrossRefPubMed
8. 8.↵
   1. Guneyli S,
   2. Atceken Z,
   3. Dogan H, et al

   . Radiological approach to COVID-19 pneumonia with an emphasis on chest CT. Diagn Interv Radiology 2020;26:323–32 doi:10.5152/dir.2020.20260

   CrossRef
9. 9.↵
   1. Ding X,
   2. Xu J,
   3. Zhou J, et al

   . Chest CT findings of COVID-19 pneumonia by duration of symptoms. Eur J Radiology 2020;127:109009 doi:10.1016/j.ejrad.2020.109009

   CrossRef
10. 10.↵
    1. Middeldorp S,
    2. Coppens M,
    3. van Haaps TF, et al

    . Incidence of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost 2020 May 5. [Epub ahead of print] doi:10.1111/jth.14888 pmid:32369666

    CrossRefPubMed
11. 11.↵
    1. Scialpi M,
    2. Scialp S,
    3. Piscioli I, et al

    . Pulmonary thromboembolism in critically ill COVID-19 patients. Int J Infect Dis 2020;95:361–62 doi:10.1016/j.ijid.2020.04.056 pmid:32339717

    CrossRefPubMed
12. 12.↵
    1. Leonard-Lorant I,
    2. Delabranche X,
    3. Severac F, et al

    . Acute pulmonary embolism in COVID-19 patients on CT angiography and relationship to D-dimer levels. Radiology 2020 Apr 23. [Epub ahead of print] doi:10.1148/radiol.2020201561 pmid:32324102

    CrossRefPubMed
13. 13.↵
    1. Grillet F,
    2. Behr J,
    3. Calame P, et al

    . Acute pulmonary embolism associated with COVID-19 pneumonia detected by pulmonary CT angiography. Radiology 2020 Apr 23. [Epub ahead of print] doi:10.1148/radiol.2020201544 pmid:32324103

    CrossRefPubMed
14. 14.↵
    1. Babapoor-Farrokhran S,
    2. Gill D,
    3. Walker J, et al

    . Myocardial injury and COVID-19: possible mechanisms. Life Sci 2020;253:117723 doi:10.1016/j.lfs.2020.117723 pmid:32360126

    CrossRefPubMed
15. 15.↵
    1. Liu K,
    2. Pan M,
    3. Xiao Z, et al

    . Neurological manifestations of the coronavirus (SARS-CoV-2) pandemic 2019-2020. J Neurol Neurosurg Psychiatry 2020;91:669–70 doi:10.1136/jnnp-2020-323177 pmid:32312873

    FREE Full Text
16. 16.↵
    1. Zanin L,
    2. Saraceno G,
    3. Panciani PP, et al

    . SARS-CoV-2 can induce brain and spine demyelinating lesions. Acta Neurochir (Wien) 2020;162:1491–94 doi:10.1007/s00701-020-04374-x pmid:32367205

    CrossRefPubMed
17. 17.↵
    1. Chen Y,
    2. Zhao M,
    3. Wu Y, et al

    . Epidemiological analysis of the early 38 fatalities in Hubei, China, of the coronavirus disease 2019. J Glob Health 2020;10:011004 doi:10.7189/jogh-10-011004 pmid:32373340

    CrossRefPubMed
18. 18.↵
    1. Beydon M,
    2. Chevalier K,
    3. Al Tabaa O, et al

    . Myositis as a manifestation of SARS-CoV-2. Ann Rheum Dis 2020 doi:10.1136/annrheumdis-2020-217573

    FREE Full Text
19. 19.↵
    1. Latronico N,
    2. Bolton CF

    . Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis. Lancet Neurol 2011;10:931–41 doi:10.1016/S1474-4422(11)70178-8

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Shepherd S,
    2. Batra A,
    3. Lerner DP

    . Review of critical illness myopathy and neuropathy. Neurohospitalist 2017;7:41‐48 doi:10.1177/1941874416663279 pmid:28042370

    CrossRefPubMed
21. 21.↵
    1. Gibson SB,
    2. Majersik JJ,
    3. Smith AG, et al

    . Three cases of acute myositis in adults following influenza-like illness during the H1N1 pandemic. J Neurosci Rural Pract 2013;4:51–54 doi:10.4103/0976-3147.105614 pmid:23546352

    CrossRefPubMed
22. 22.↵
    1. Dalakas MC,
    2. Pezeshkpour GH,
    3. Gravell M, et al

    . Poly-myositis associated with AIDS retrovirus. JAMA 1986;256:2381–83 doi:10.1001/jama.1986.03380170097026

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Dalakas MC,
    2. Pezeshkpour GH

    . Neuromuscular diseases associated with human immunodeficiency virus infection. Ann Neurol 1988;23:S38–S48 doi:10.1002/ana.410230713

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Villanova M,
    2. Caudai C,
    3. Sabatelli P, et al

    . Hepatitis C virus infection and myositis: a polymerase chain reaction study. Acta Neuropathol 2000;99:271–76 doi:10.1007/pl00007437 pmid:10663969

    CrossRefPubMed
25. 25.↵
    1. Alsaad KO,
    2. Hajeer AH,
    3. Al Balwi M, et al

    . Histopathology of Middle East respiratory syndrome coronovirus (MERS-CoV) infection—clinicopathological and ultrastructural study. Histopathology 2018;72:516–24 doi:10.1111/his.13379 pmid:28858401

    CrossRefPubMed